On November 6, during the 6th China International Import Expo (CIIE), Sinopharm Group and Roche Pharmaceuticals China held a strategic cooperation signing ceremony. Chen Zhanyu, Vice President of Sinopharm Group, and Ding Xia, Head of Multichannel Ecosystem Expansion at Roche Pharmaceuticals China, signed the agreement on behalf of both parties. Liu Yong, President and Executive Director of Sinopharm Group, Kong Xuedong, Chairman of the Global Procurement and Supply Chain Service Center of Sinopharm Group, Liu Tianyao, General Manager, and Vice Presidents Zhao Min and Xu Hai were present at the event. From Roche Pharmaceuticals China, participants included Bian Xin, President, Qian Wei, General Manager of the Oncology Division, Chen Yijuan, Vice President of the Specialty Medicines Division, Li Bin, Vice President of the Medical and Personalized Healthcare Division, and Ryan Harper, Vice President of Product Pipeline Strategy and Digital Innovation. They all witnessed this milestone moment.
Next year marks the 30th anniversary of Roche Pharmaceuticals China in the Chinese market. Roche Pharmaceuticals China and Sinopharm Group have always maintained a close partnership, building a deep cooperative friendship over the years. Through this strategic signing, Sinopharm Group and Roche Pharmaceuticals China will leverage their respective strengths to continue deepening cooperation across multiple fields, elevating their partnership to new heights.
Liu Yong, President and Executive Director of Sinopharm Group, expressed gratitude for Roche Pharmaceuticals China’s ongoing support and trust. He noted that through this strategic signing, Sinopharm Group and Roche Pharmaceuticals China will continue to deepen cooperation in various fields, jointly accelerating the market entry of new products and working together to create an innovative, collaborative, and diversified local healthcare ecosystem.
Bian Xin, President of Roche Pharmaceuticals China, remarked that Sinopharm Group, as a leading distributor and retailer of pharmaceuticals and medical devices in China, as well as a leading supply chain service provider, has always been an important partner for Roche Pharmaceuticals China. In recent years, Roche Pharmaceuticals China has focused on accelerating the introduction of multiple global innovative products and promoting their deep integration with the local ecosystem. Bian Xin emphasized that whether in product distribution, supply chain collaboration, hospital access, or out-of-hospital markets, Roche looks forward to comprehensive cooperation with Sinopharm Group in the future, continuously exploring new models and jointly expanding new channels.
The successful signing of this strategic cooperation agreement marks the beginning of a new chapter in the partnership between the two companies. Going forward, both parties will adhere to a “patient-centered” development philosophy, continue to deepen cooperation, share opportunities brought by the CIIE, and jointly promote the efficient implementation of innovative products across various disease areas. This collaboration aims to create a new ecosystem model for diagnosis and treatment, contribute to the realization of the “Healthy China 2030″ initiative, and provide more options for patients in need.
